Trending Report – Undergoing Treatment or Banking Stem Cells
There’s not yet strong clinical evidence for the efficacy and safety of these treatments and none have been approved by the FDA. So before delving into the world of regenerative medicine and treatments that use adult stem cells, it’s wise to learn more about the current clinical landscape.
Decision Support Strategies to Drive Better Health Outcomes
This paper brings together current research related to the complexities of treatment decisions and the associated rising costs. It also examines current research and new data on how a range of decision support strategies can help manage risk, drive patient engagement in healthcare decision making, and improve medical outcomes.
The Human Cost and Financial Impact of Misdiagnosis.
This paper summarizes the key research findings on the frequency, human cost, and financial impact of these diagnostic errors, while providing new data on the value of second opinions. An extensive Institute of Medicine (IOM) report underscores the importance of this with its conclusion that most Americans will receive an inaccurate or late diagnosis at least once in their lives, often with
Driving Engagement and Lowering Costs
Personalizing the service and intervening at a granular level to develop a one-to-one relationship with the patient is paramount to a successful outcome. A complex and serious diagnosis does not have to be the end. It is where a health advisor begins to help employees navigate through a potentially life-changing medical issue – facilitating their access to the right care at the right time to guide them along their journey.